Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 1,989,994 |
|
|||||
| News | (2) | ||||||
| Day High | 0.24 | Low High |
|||||
| Day Low | 0.223 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| TransCode Therapeutics Inc | RNAZ | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.001 | 0.46% | 0.22 | 18:59:43 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.23 | 0.223 | 0.24 | 0.228 | 0.219 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,949 | 1,989,994 | US$ 0.233147 | US$ 463,961 | - | 0.1494 - 23.40 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:58:06 | formt | 1,500 | US$ 0.22 | USD |
TransCode Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.62M | 20.10M | - | 0 | -17.57M | -0.87 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
TransCode Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 12/04/2023 | 16:07 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/04/2023 | 15:10 | GlobeNewswire Inc. | TransCode Therapeutics Announces Closing of $1.2 Million.. |
| 12/01/2023 | 16:23 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 11/30/2023 | 13:53 | GlobeNewswire Inc. | TransCode Therapeutics Announces $1.2 Million Registered.. |
| 11/14/2023 | 15:40 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/14/2023 | 15:30 | GlobeNewswire Inc. | TransCode Therapeutics Reports Third Quarter 2023 Results;.. |
| 11/09/2023 | 15:13 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/31/2023 | 21:20 | AllPennyStocks.com | Biotech Shares Bid Up Following Public Offering Cancellation |
| 10/30/2023 | 15:33 | GlobeNewswire Inc. | TransCode Therapeutics Withdraws Public Offering |
| 10/27/2023 | 15:06 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/27/2023 | 07:00 | GlobeNewswire Inc. | Nasdaq Panel Grants TransCode Therapeutics Extension for.. |
| 10/26/2023 | 15:29 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RNAZ Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.23 | 0.4666 | 0.2105 | 0.2435474 | 7,748,716 | -0.01 | -4.35% |
| 1 Month | 0.364 | 0.4856 | 0.1494 | 0.2627356 | 3,117,405 | -0.144 | -39.56% |
| 3 Months | 1.03 | 3.20 | 0.1494 | 0.8961845 | 7,511,455 | -0.81 | -78.64% |
| 6 Months | 3.95 | 4.16 | 0.1494 | 0.961716 | 3,646,428 | -3.73 | -94.43% |
| 1 Year | 8.542 | 23.40 | 0.1494 | 6.38 | 2,999,204 | -8.32 | -97.42% |
| 3 Years | 120.00 | 140.00 | 0.1494 | 27.55 | 1,822,492 | -119.78 | -99.82% |
| 5 Years | 120.00 | 140.00 | 0.1494 | 27.55 | 1,822,492 | -119.78 | -99.82% |
TransCode Therapeutics Description
| TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regression without recurrence in a range of cancers, including breast, pancreatic, ovarian and colon cancer, glioblastomas and others. |
